Detail akcie H&R Br online

Business Summary: H&R GmbH & Co KGaA is a Germany-based developer and manufacturer of crude oil-based chemical and pharmaceutical products and precision plastic components. It operates through three segments: Chemical-Pharmaceutical Raw Materials Refining (ChemPharm Refining), Chemical-Pharmaceutical Raw Materials Sales (ChemPharm Sales) and Plastics. The ChemPharm Refining segment comprises two refineries in Germany, which produce plasticizers, paraffins, white oils and base oils; the ChemPharm Sales segment includes production and distribution sites worldwide and its main products are label-free plasticizers for the tire industry, as well as paraffins for various applications, and the Plastics segment produces precision plastic parts and molding tools to manufacture precision plastic parts.
Financial Summary: BRIEF: For the fiscal year ended 31 December 2023, H&R GmbH & Co KgaA revenues decreased 14% to EUR1.35B. Net income decreased 75% to EUR10.6M. Revenues reflect ChemPharm Refining segment decrease of 19% to EUR808.2M, ChemPharm Sales segment decrease of 6% to EUR492.7M, Germany segment decrease of 19% to EUR707.2M, Rest of world. segment decrease of 6% to EUR452.4M.